GERN
GERON CORP
NASDAQ · Healthcare · Biotechnology · US
$1.30
−1.52%Forward multiples
Based on analyst estimates
- P/E forward
- 77.66x
- P/E 2026E
- —
- P/E 2027E
- 17.57x
- P/E 2028E
- 5.20x
- P/S forward
- 2.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.82x
- Price / sales
- 4.08x
- Price / cash flow
- -7.30x
Enterprise value
- Enterprise value
- $656.5M
- EV / sales
- 3.21x
- EV / EBITDA
- -15.73x
- EV / EBIT
- -17.55x
- Market cap
- $835.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026